Delivery Order SPE2DB22D3016-SPE2DB25FBCJ9
Award Date 7/21/25
Potential Completion Date 8/11/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,356.89 and is for the supply of XALKORI 250 MG CAPSULE 60S, a prescription medication. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,865.21 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 24, 2024, with a completion date of July 16, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,419.30 contract is for the delivery of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, with a completion date of July 8, 2025. The contract is not set aside and allows for the supply of a wide range of pharmaceutical and medical products to support military healthcare...
- This federal contract award, valued at $12,679.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. This award is not associated with a set-aside program and was made through full and open competition. The prime contractor, AmerisourceBergen Drug Corp, is a subsidiary of Cencora, Inc., a larger pharmaceutical distribution company. This...
- This federal contract award, valued at $14,356.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product, with a performance period extending through May 28, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
- This $25,385.80 firm fixed price delivery order was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for the delivery of 4562568861 XALKORI 200 MG CAPSULE 60S to a location in Conshohocken, Pennsylvania. The order is for the delivery of oncology pharmaceutical products to support DLA programs and has a completion date of November 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a for-profit organization that will perform the order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $12,865.21 firm-fixed-price contract is for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $96,570.52 firm fixed-price delivery order is for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $14,356.89 firm fixed price contract is for the delivery of XALKORI 250 MG CAPSULE 60S, with a performance period through June 2025. The contract is not set aside and allows for the provision of a wide range of pharmaceutical and medical products to support military healthcare programs....
- The Defense Logistics Agency Troop Support Medical awarded a $12,679 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561829964 XALKORI 250 MG CAPSULE 60S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on August 16, 2023 through September 7, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support for the Department of Defense,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBCJ9Delivery Order
4568850366 ! XALKORI 200 MG CAPSULE 60S
Posted 7/21/25
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 7/21/25 |